ABIVAX
Live / Applied — Third extension granted (statement of use) (as of 09 Oct 2025)
What this means for you
Not registered yet, but its 09 May 2022 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97400995
- Mark type
- Stylized text
- Filed
- 09 May 2022
- Published for opposition
- 27 Jun 2023
- Attorney of record
- Jennifer Insley-Pruitt
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the prevention of autoimmune, inflammatory, gastrointestinal disease; Pharmaceutical preparations for the prevention and treatment of oncologic, metabolic, rheumatic, dermatological, endocrine, ophthalmologic, neurologic, cardiovascular, musculoskeletal, viral, and fungal disease; vaccines for human and veterinary use; adjuvants for use with vaccines
Owner
Prosecution history
- 09 Oct 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 09 Oct 2025 — SOU EXTENSION 3 GRANTED
- 29 Sept 2025 — SOU EXTENSION 3 FILED
- 30 Sept 2025 — SOU TEAS EXTENSION RECEIVED
- 22 Sept 2025 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
- 22 Sept 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 22 Sept 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 22 Sept 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 19 Sept 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 18 Sept 2025 — CORRECTED NOA E-MAILED
- 18 Sept 2025 — SOU EXTENSION 2 GRANTED
- 06 Apr 2025 — SOU EXTENSION 2 FILED
- 18 Sept 2025 — DIVISIONAL PROCESSING COMPLETE
- 07 Apr 2025 — DIVISIONAL REQUEST RECEIVED
- 18 Sept 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL